Paper4652000
Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid).
Bollag W. Eur J Cancer (1965), 1972. Cited by 349 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid). Papers, record 4652000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4652000
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid).
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatty Acids, Unsaturated | Major topic |
| Skin Neoplasms | Major topic |
| Vitamin A | Major topic |
| Administration, Oral | |
| Animals | |
| Benz(a)Anthracenes | |
| Carcinoma | |
| Croton Oil | |
| Female | |
| Mice | |
| Neoplasms, Experimental | |
| Papilloma |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 349 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,151,346 | Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions. | Arch Dermatol Res | 2021 | https://conductscience.org/library/papers/33151346 | PubMed |
| 28,305,187 | Structure-activity relationship of retinoids on the differentiation of cultured chick foot skin. | Wilehm Roux Arch Dev Biol | 1984 | https://conductscience.org/library/papers/28305187 | PubMed |
| 28,304,921 | Retinoic acid induced proteoglycan release and cartilage resorption in rat bone cultures are age dependent and inhibited by EDTA. | Wilehm Roux Arch Dev Biol | 1979 | https://conductscience.org/library/papers/28304921 | PubMed |
| 22,358,623 | Effect of retinoic acid on the proliferation and tumorigenicity of mouse mastocytoma cells : Effect of retinoic acid on mastocytoma cells. | Cytotechnology | 1989 | https://conductscience.org/library/papers/22358623 | PubMed |
| 17,234,230 | Polyamines and nonmelanoma skin cancer. | Toxicol Appl Pharmacol | 2007 | https://conductscience.org/library/papers/17234230 | PubMed |
| 8,520,168 | Effect of dietary vitamin A on forestomach tumorigenesis during the total and postinitiation stages in mice treated with high- or low-dose benzo(a)pyrene. | Surg Today | 1995 | https://conductscience.org/library/papers/8520168 | PubMed |
| 7,283,473 | Lack of enhancement of experimental photocarcinogenesis by topical retinoic acid. | Arch Dermatol Res | 1981 | https://conductscience.org/library/papers/7283473 | PubMed |
| 7,084,974 | Modulation of mammalian cell growth by a choline analog, N-isopropylethanolamine. | In Vitro | 1982 | https://conductscience.org/library/papers/7084974 | PubMed |
| 7,007,222 | Anti-cancer action of retinoids. | Immunology | 1981 | https://conductscience.org/library/papers/7007222 | PubMed |
| 6,948,686 | Inhibition of phorbol myristate acetate and phytohemagglutinin stimulation of human lymphocytes by 13-cis-retinoic acid and ethyl etrinoate. | Experientia | 1981 | https://conductscience.org/library/papers/6948686 | PubMed |
| 6,940,759 | Effects of retinoic acid on the fibrinolytic activity of HL 60 human promyelocytic leukemia cells. | Experientia | 1981 | https://conductscience.org/library/papers/6940759 | PubMed |
| 6,843,303 | Phospholipid composition of liver in rats fed high levels of 13-cis retinoic acid. | Lipids | 1983 | https://conductscience.org/library/papers/6843303 | PubMed |
| 6,386,427 | Psoriasis. A review of recent advances in treatment. | Drugs | 1984 | https://conductscience.org/library/papers/6386427 | PubMed |
| 6,272,736 | Phorbol esters induce synthesis of thromboplastin activity in human monocytes. | Biochem J | 1981 | https://conductscience.org/library/papers/6272736 | PubMed |
| 6,230,219 | Vitamin therapy in the absence of obvious deficiency. What is the evidence? | Drugs | 1984 | https://conductscience.org/library/papers/6230219 | PubMed |
| 4,435,135 | Antitumor effect of a new retinoic acid analog. | Experientia | 1974 | https://conductscience.org/library/papers/4435135 | PubMed |
| 4,281,973 | [Investigation on the cytostatic mechanism of vitamin-A-acid (author's transl)]. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1974 | https://conductscience.org/library/papers/4281973 | PubMed |
| 4,068,803 | Vitamin deficiency and cancer. | Med Oncol Tumor Pharmacother | 1985 | https://conductscience.org/library/papers/4068803 | PubMed |
| 3,882,304 | Clinical pharmacokinetics of the retinoids. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/3882304 | PubMed |
| 3,876,274 | High dietary vitamin A (retinyl palmitate) and cellular immune functions in mice. | Immunology | 1985 | https://conductscience.org/library/papers/3876274 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4652000
GET https://conductscience.org/api/papers/v1/4652000/cited_by?page=2